Form 4 for KURA Kura Oncology, Inc.
Accepted 2026-01-27 00:00:00 ET · period of report 2026-01-27 · accession 0001193125-26-025305 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-01-27 | 2026-01-27 | KURA | Powl Brian T. | Chief Commercial Off | S - Sale | $8.46 | -6,414 | 184.8K | -3% | -$54.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-27 | S | D | 1,572 | $8.46 | 183,275 | D | — | — | (F2) Sell-to-cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/2/24. |
| 2 | Common | Common Stock | 2026-01-27 | S | D | 4,842 | $8.46 | 184,847 | D | — | — | (F1) Sell-to-cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/2/25. |